FENNEC PHARMACEUTICALS INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Fennec Pharmaceuticals Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$533K, a 37.3% increase year-over-year.
  • Fennec Pharmaceuticals Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$2.82M, a 10.1% increase year-over-year.
  • Fennec Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2023 was -$3.27M, a 191% decline from 2022.
  • Fennec Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2022 was -$1.13M, a 815% decline from 2021.
  • Fennec Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2021 was -$123K, a 45.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.82M -$533K +$317K +37.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$3.13M -$514K +$264K +33.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$3.4M -$906K -$124K -15.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$3.27M -$864K -$142K -19.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$3.13M -$850K -$660K -347% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$2.47M -$778K -$715K -1135% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$1.76M -$782K -$632K -421% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$1.13M -$722K -$502K -228% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$623K -$190K -$178K -1483% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$445K -$63K +$18K +22.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$463K -$150K -$340K -179% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$123K -$220K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$12K +$329K +96.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$81K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $190K +$181K +2011% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$341K -$395K -731% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q1 2020 $189K $9K -$45K -83.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $234K $43K -$78K -64.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $312K $54K -$45K -45.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $357K $83K +$5K +6.41% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $352K $54K -$169K -75.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $521K $121K -$104K -46.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 $625K $99K +$265K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $360K $78K +$197K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $163K $223K +$258K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$95K $225K +$222K +7400% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$317K -$166K -$228K -368% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$89K -$119K -$102K -600% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $13K -$35K -$69K -203% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $82K $3K -$8K -72.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 $90K $62K -$153K -71.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $243K -$17K -$393K -105% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $636K $34K -$595K -94.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 $1.23M $11K -$2.17M -99.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 $3.4M $215K -$784K -78.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $4.18M $376K +$196K +109% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $3.99M $629K +$3.29M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $701K $2.18M +$651K +42.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 $50K $999K +$2.71M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.66M $180K -$7.35M -97.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $4.69M -$2.66M +$914K +25.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $3.78M $1.53M +$6.92M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$3.14M -$1.72M -$1.58M -1180% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$1.56M $7.53M +$6.89M +1063% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$8.45M -$3.57M -$6.9M -207% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$1.54M -$5.39M -$9.8M -222% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 $8.25M -$134K +$2.07M +93.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 $6.19M $648K +$424K +189% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $5.76M $3.33M -$2.36M -41.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 $8.12M $4.41M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 -$2.2M -$4.81M -184% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $224K +$288K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 $5.69M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $2.61M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$64K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.